[
  {
    "ts": null,
    "headline": "Is Trending Stock Amgen Inc. (AMGN) a Buy Now?",
    "summary": "Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=dc073fa99bf28c675e79c8c0c1d816b6126513f9ac4c731c7278d4806a5d943e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759928402,
      "headline": "Is Trending Stock Amgen Inc. (AMGN) a Buy Now?",
      "id": 137011008,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=dc073fa99bf28c675e79c8c0c1d816b6126513f9ac4c731c7278d4806a5d943e"
    }
  },
  {
    "ts": null,
    "headline": "2 S&P 500 Stocks to Target This Week and 1 Facing Challenges",
    "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
    "url": "https://finnhub.io/api/news?id=0b252416d18d66e953b01c8fa1616cc74e62f385c4e8c99d9a460996dfcecaa2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759898115,
      "headline": "2 S&P 500 Stocks to Target This Week and 1 Facing Challenges",
      "id": 137010134,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
      "url": "https://finnhub.io/api/news?id=0b252416d18d66e953b01c8fa1616cc74e62f385c4e8c99d9a460996dfcecaa2"
    }
  },
  {
    "ts": null,
    "headline": "Does Amgen’s Recent 4.7% Surge Signal Room for Growth in 2025?",
    "summary": "If you are scratching your head about whether to buy, sell, or just hold on to Amgen stock, you are not alone. The biotech giant has had an interesting run. Just last week, shares jumped 4.7%, capping off a month that saw a 4.2% gain. Year to date, Amgen has climbed an impressive 14.0%. That kind of momentum, especially after a softer 1-year return of -3.9%, has caught a lot of investors’ attention and triggered plenty of debate about what is next. Much of the recent optimism seems tied to...",
    "url": "https://finnhub.io/api/news?id=7bdd2b59658e1c078f1852fd1ade3496bfa8229aaf3652f2fb02ff7643db2851",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759898082,
      "headline": "Does Amgen’s Recent 4.7% Surge Signal Room for Growth in 2025?",
      "id": 137008058,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "If you are scratching your head about whether to buy, sell, or just hold on to Amgen stock, you are not alone. The biotech giant has had an interesting run. Just last week, shares jumped 4.7%, capping off a month that saw a 4.2% gain. Year to date, Amgen has climbed an impressive 14.0%. That kind of momentum, especially after a softer 1-year return of -3.9%, has caught a lot of investors’ attention and triggered plenty of debate about what is next. Much of the recent optimism seems tied to...",
      "url": "https://finnhub.io/api/news?id=7bdd2b59658e1c078f1852fd1ade3496bfa8229aaf3652f2fb02ff7643db2851"
    }
  }
]